Zhu et al.’s meta-analysis reported that elevated biomarkers, including Troponins I and NT-proBNP, were associated with severe COVID-19 forms, similar to Cersosimo et al., who highlighted the role of troponins in predicting mortality [32,33]. Here, NPPB is linked to COVID-19.